arginyl-glycyl-aspartic acid has been researched along with Liver Cirrhosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chida, T; Hanaoka, T; Ito, J; Kawata, K; Kitsugi, K; Matsumoto, M; Neuschwander-Tetri, BA; Noritake, H; Ohta, K; Suda, T; Takatori, S; Ulmasov, B; Umemura, M; Yamashita, M | 1 |
| Chen, J; Dai, G; Hou, Y; Ji, G; Liu, Y; Song, Z; Yang, J; Zhang, Y | 1 |
| Birukawa, NK; Fujita, R; Kajiwara, K; Kosaka, A; Minomi, K; Miyazaki, M; Murakami, Y; Murase, K; Nakashima, Y; Niitsu, Y; Ninomiya, T; Nishimura, M; Nishita, H; Ota, S; Sato, Y; Tamura, Y; Tanaka, Y; Yoneda, A | 1 |
| Cui, Y; Li, X; Liu, H; Wang, D; Zhang, C; Zhang, Y; Zhang, Z | 1 |
| Huang, XW; Li, F; Lu, WY; Song, ZJ; Wang, JY; Xie, C | 1 |
| Shimizu, I | 1 |
| Enjoji, M; Fukushima, M; Kobayashi, N; Kohjima, M; Kotoh, K; Morizono, S; Nakamuta, M; Nawata, H | 1 |
| Du, SL; Lu, WY; Pan, H; Wang, J; Wang, JY; Wu, J | 1 |
1 review(s) available for arginyl-glycyl-aspartic acid and Liver Cirrhosis
| Article | Year |
|---|---|
Antifibrogenic therapies in chronic HCV infection.
Topics: Antioxidants; Hepatitis C, Chronic; Hepatocyte Growth Factor; Hepatocytes; Humans; Interferons; Liver Cirrhosis; Oligopeptides; Retinoids; T-Lymphocytes, Cytotoxic; Transforming Growth Factor beta | 2001 |
7 other study(ies) available for arginyl-glycyl-aspartic acid and Liver Cirrhosis
| Article | Year |
|---|---|
Arg-Gly-Asp-binding integrins activate hepatic stellate cells via the hippo signaling pathway.
Topics: Arginine; Aspartic Acid; Focal Adhesion Protein-Tyrosine Kinases; Glycine; Hepatic Stellate Cells; Hippo Signaling Pathway; Humans; Integrins; Liver Cirrhosis; Oligopeptides; Phosphatidylinositols; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Transforming Growth Factor beta; YAP-Signaling Proteins | 2022 |
Targeted delivery of the RGD-labeled biodegradable polymersomes loaded with the hydrophilic drug oxymatrine on cultured hepatic stellate cells and liver fibrosis in rats.
Topics: Actins; Alkaloids; Animals; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Drug Carriers; Gene Expression; Hepatic Stellate Cells; Hydrophobic and Hydrophilic Interactions; Lactones; Liver; Liver Cirrhosis; Male; Maleimides; Nanostructures; Oligopeptides; Polyesters; Polyethylene Glycols; Quinolizines; Rats; Rats, Wistar | 2014 |
Activated hepatic stellate cells are dependent on self-collagen, cleaved by membrane type 1 matrix metalloproteinase for their growth.
Topics: Animals; Apoptosis; Cell Proliferation; Cell Survival; Collagen; Hepatic Stellate Cells; HSP47 Heat-Shock Proteins; Humans; I-kappa B Proteins; Integrins; Liver Cirrhosis; Matrix Metalloproteinase 14; Matrix Metalloproteinase Inhibitors; Mice; Oligopeptides; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1 | 2014 |
Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ₃ for staging liver fibrosis in rat model.
Topics: Animals; Carbon Tetrachloride; Dextrans; Disease Models, Animal; Hepatic Stellate Cells; Integrin alphaVbeta3; Liver Cirrhosis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Oligopeptides; Rats | 2016 |
Biochemical characterization of the binding of cyclic RGDyK to hepatic stellate cells.
Topics: Amino Acid Sequence; Animals; Blotting, Western; Cells, Cultured; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Hepatic Stellate Cells; Indoles; Integrin alphaVbeta3; Iodine Radioisotopes; Liver Cirrhosis; Male; Oligopeptides; Peptides; Protein Binding; Radioligand Assay; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2010 |
Arg-Gly-Asp (RGD) peptide ameliorates carbon tetrachloride-induced liver fibrosis via inhibition of collagen production and acceleration of collagenase activity.
Topics: Animals; Carbon Tetrachloride; Cell Line; Collagen; Collagenases; Gene Expression Regulation; Humans; Hydroxyproline; Liver; Liver Cirrhosis; Male; Matrix Metalloproteinase 1; Oligopeptides; Rats; Rats, Wistar; Tissue Inhibitor of Metalloproteinase-1 | 2004 |
Cyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats.
Topics: Alanine Transaminase; Animals; Cell Proliferation; Cells, Cultured; Cholestasis, Extrahepatic; Collagen Type I; Collagen Type III; Drug Delivery Systems; Endocytosis; Gene Expression; Hepatocytes; Hydroxyproline; Interferon-alpha; Liver; Liver Cirrhosis; Male; Maleimides; Oligopeptides; Peptides, Cyclic; Pericytes; Phosphatidylethanolamines; Polyethylene Glycols; Rats; Rats, Wistar; Unilamellar Liposomes | 2007 |